The Joint Corp.

JYNT Healthcare Medical Care Facilities

The Joint Corp.’s revenue for fiscal 2025 (year ended December 2025) was $54.9 million, up 5.24% from fiscal 2024.

Revenue
+14.4%
EPS
+400.0%
Free cash flow
+432.3%

Quarter to June 2026, against a year earlier

6.89 0.48 −6.51%
Market cap
$104.2M
P/E
25.5×
Fwd P/E
20.1×
Dividend yield
—
F-score
7/9
Altman Z
2.39
Beneish M
−2.27
Dividend safety
n/a

The Joint Corp. (JYNT) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, The Joint Corp. (JYNT) trades at a EV/Sales of 1.3×. Over the past ten years it has ranged from 0.8× (March 2016) to 21.6× (September 2021); the current reading is higher than 6% of that period. That is in line with the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.0× (22.57%)
FY2024 2.6× 145.75%
FY2023 1.1× (44.91%)
FY2022 1.9× (83.51%)
FY2021 11.6× 92.82%
FY2020 6.0× 33.99%
FY2019 4.5× 54.93%
FY2018 2.9× 16.86%
FY2017 2.5× 66.66%
FY2016 1.5× (52.18%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.8× (5.10%)
Mar 2026 1.9× (6.25%)
Dec 2025 2.0× (7.57%)
Sep 2025 2.2× (21.47%)
42 more quarters

Against its own ten years

Low 0.8× High 21.6×
Ten-year median 2.6×
Current reading's percentile 7

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on JYNT